ondansetron has been researched along with Rhabdomyosarcoma in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Rhabdomyosarcoma: A malignant solid tumor arising from mesenchymal tissues which normally differentiate to form striated muscle. It can occur in a wide variety of sites. It is divided into four distinct types: pleomorphic, predominantly in male adults; alveolar (RHABDOMYOSARCOMA, ALVEOLAR), mainly in adolescents and young adults; embryonal (RHABDOMYOSARCOMA, EMBRYONAL), predominantly in infants and children; and botryoidal, also in young children. It is one of the most frequently occurring soft tissue sarcomas and the most common in children under 15. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p2186; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1647-9)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, CY | 1 |
| Ratnapalan, S | 1 |
| Thompson, M | 1 |
| Nathan, PC | 1 |
| Closs, J | 1 |
| French, A | 1 |
| Punnett, A | 1 |
| Garcia-Bournissen, F | 1 |
| Ito, S | 1 |
| Koren, G | 1 |
1 other study available for ondansetron and Rhabdomyosarcoma
| Article | Year |
|---|---|
Unusual reactions to 5-HT3 receptor antagonists in a child with rhabdomyosarcoma.
Topics: Antiemetics; Antineoplastic Agents; Child; Facial Muscles; Humans; Male; Ondansetron; Rhabdomyosarco | 2010 |